Center for Biologics Evaluation and Research (CBER), USFDA United States of America (USA)
Date range: 1 July 2021 - 30 June 2022
Parent institution:Office of Medical Products and Tobacco, USFDA
Subject/journal group: All
The table to the right includes counts of all research outputs for Center for Biologics Evaluation and Research (CBER), USFDA published between 1 July 2021 - 30 June 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
Share output for the past 5 years
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.